Nature Biotechnology 20th Anniversary

Content

• Breaking out of the bubble

  The biotech community has made remarkable progress over the past 20 years. Now it needs to break out of its bubble.

  Editorial10 Mar 2016 Nature Biotechnology
• 

  Estimating the biotech sector's contribution to the US economy

  US biotech sector revenue is estimated to have grown on average >10% each year over the past decade—much faster than the rest of the economy. A more comprehensive assessment of biotech's economic contribution, however, will require improved data collection, classification and analysis.

  • Robert Carlson

  Feature10 Mar 2016 Nature Biotechnology
• 

  20 years of Nature Biotechnology research tools

  Authors of some of the most highly cited Nature Biotechnology papers that describe research tools discuss their work and challenges for their fields.

  • Anna Azvolinsky
  • Laura DeFrancesco
  • Sarah Webb

  Feature10 Mar 2016 Nature Biotechnology
• 

  20 years of Nature Biotechnology biomedical research

  Authors of some of the most highly cited Nature Biotechnology biomedical papers from the past 20 years discuss their work and challenges for their fields.

  • Anna Azvolinsky
  • Charles Schmidt
  • Sarah Webb

  Feature10 Mar 2016 Nature Biotechnology
• 

  20 years of Nature Biotechnology bioengineering research

  Authors of some of the most highly cited Nature Biotechnology nonbiomedical papers from the past 20 years discuss their work and challenges for their fields.

  • Laura DeFrancesco
  • Charles Schmidt
  • Emily Waltz

  Feature10 Mar 2016 Nature Biotechnology
• 

  Voices of biotech

  Nature Biotechnology asks a selection of researchers about the most exciting frontier in their field and the most needed technologies for advancing knowledge and applications.

  • Ido Amit
  • David Baker
  • Tian Zhang

  Feature10 Mar 2016 Nature Biotechnology
• 

  Community crystal gazing

  A selection of individuals from the biotech ecosystem give their views on the challenges facing the sector over the coming years.

  • Anu Acharya
  • Kate Bingham
  • Daphne Zohar

  Feature10 Mar 2016 Nature Biotechnology
• 

  When biotech goes bad

  A look at 20 years of the dark side of biotech.

  • John Hodgson

  Feature10 Mar 2016 Nature Biotechnology
• 

  The changing life science patent landscape

  What have we learned from 20 tumultuous years of patent law in the life sciences? Is patenting likely to be as important for the industry in the future?

  • Arti K Rai
  • Jacob S Sherkow

  Patents10 Mar 2016 Nature Biotechnology